UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2023 

Commission File Number: 001-31995

 

MEDICURE INC.

(Translation of registrant’s name into English)

 

 

2-1250 Waverley Street

Winnipeg, MB Canada R3T 6C6

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒     Form 40-F ☐

 

 

 

  

EXHIBIT LIST

 

Exhibit

 

Title

 

 

 

99.1

 

News Release

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

 

Medicure Inc.

 

(Registrant)

 

       
Date: May 26, 2023 By: /s/ Dr. Albert D. Friesen

 

 

Dr. Albert D. Friesen

  
  Title: CEO  
       

 

 

3

 

 

Medicure (PK) (USOTC:MCUJF)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Medicure (PK).
Medicure (PK) (USOTC:MCUJF)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Medicure (PK).